ORIC-944, a PRC2 inhibitor with best-in-class properties, restores luminal features and restricts adaptation in prostate cancer models, conferring synergy with AR pathway inhibitors ORIC-944 is a ...

Both TB treatment and TB preventive therapy involve taking lots of pills, usually for several months. Researchers are working ...

Q4 2024 Earnings Conference Call March 25, 2025 8:30 AM ETCompany ParticipantsJianping Kong - Chairman and CEOBing Chen ...

Psyence Group Inc ("Psyence Group" or the "Company") (CSE: PSYG) is pleased that its NASDAQ-listed associate, Psyence Biomedical Ltd (NASDAQ: PBM) ("PBM" or "Psyence Biomed"), has announced that it ...

Consumers today are spoiled for choice when choosing credit cards. It’s tough for issuers to stand out in such a crowded ...

The agency has published a list of 24 high-risk infectious diseases as a reference tool for funders and researchers.

The First Eagle Global Fund fund is rated five stars (the highest rating) by Morningstar within the investment information provider's "Large Value, Global Allocation" category. The total return for ...

Meharry Medical College could lose millions amid proposed NIH cuts to research and Trump's mission to stop DEI programs. Jobs ...

In today’s fast-paced industrial world, the pressure to innovate while maintaining efficiency and minimizing costs is ...

Dr. Karen DeSalvo, chief health officer at Google, said the company is working with partners to build trust in its AI models.

AsianFin -- After a six-month hiatus, former Huawei "Genius Youth" Peng Zhihui has secured another round of funding for his ...